EU funds for Israeli alternative insulin therapy

Israel’s Betalin Therapeutics (see here previously) is to receive capital from the European Innovation Council (EIC) fund. The funding will advance human trials of its biological pancreas that can produce insulin in the body independently, thus making injections unnecessary.,7340,L-3912996,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.